Dr. Pranab M. Barman, MD

Dr. Barman practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Barman's NPI, 1023301991, was assigned on May 25, 2011. Dr. Barman graduated from Boston University School Of Medicine in 2011. Dr. Barman holds California license A162554.

Dr. Barman's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Barman's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Barman is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health. Dmand AI also links Dr. Barman to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Barman practices, 2 sites in all. Vendor and product names are available with a free account.

Transplant hepatology is Dr. Barman's primary specialty in the NPI Registry, under taxonomy code 207RT0003X. Dr. Barman is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Barman's licenses on file in 4 states: California, Illinois, North Carolina and Michigan.

Dmand AI lists cirrhosis of the liver, colonoscopy, fatty liver, hepatitis c and upper GI endoscopy among the conditions Dr. Barman treats.

CMS data shows 295 Medicare services from Dr. Barman across 5 procedure codes in 2024, for 176 Medicare patients. Medicare paid $33,705 for them.

CMS counts 176 Medicare patients who saw Dr. Barman in 2024. The largest group is 65 to 74, with 100 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 54% are also on Medicaid. Their average risk score is 3.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Barman's median patient age at 58, with 53% women.

In 2024, Dr. Barman wrote 466 Medicare Part D claims for 97 patients. 73% of them were for generic drugs. CMS names the drug for 313 of them, across 13 drugs with 11 or more claims each, at $143,217 in total drug cost. In 2023, CMS named 320 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Barman for performance year 2024, reported as part of a group. Dr. Barman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Barman as offering telehealth. CMS counts 21 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Barman, more than 51% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 26 papers to Dr. Barman, published from 2011 to 2025. 2023 was the busiest year, with 6. The most frequent topics are Liver Transplantation, Kidney Transplantation and End Stage Liver Disease. Dr. Barman has published most often in Liver Transpl. Dr. Barman's most frequent co-authors are Yuval Adrash Dinesh Patel, MD, Lisa B. Vanwagner, MD and Giuseppe Cullaro, MD.

CMS Open Payments shows 20 general payments to Dr. Barman from 9 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 60% of the total. Bausch Health Americas, Inc. paid the most, $1,435.

Dr. Barman graduated from Boston University School Of Medicine in 2011.

Dr. Barman is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.